# A Cardiac Liability Study of Varegacestat in Healthy Participants

> **NCT06855264** · PHASE1 · COMPLETED · sponsor: **Immunome, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** varegacestat
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin 400 mg

## Key facts

- **NCT ID:** NCT06855264
- **Lead sponsor:** Immunome, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-24
- **Primary completion:** 2025-04-08
- **Final completion:** 2025-05-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855264, "A Cardiac Liability Study of Varegacestat in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06855264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*